Associated factors of atrophic gastritis diagnosed by double-contrast upper gastrointestinal barium X-ray radiography: A cross-sectional study analyzing 6,901 in Japan

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Yamamichi, Nobutake ^a   Hirano, Chigaya ^b   Shimamoto, Takeshi ^a,b   Minatsuki, Chihiro ^a   Takahashi, Yu ^a   Nakayama, Chiemi ^a   Matsuda, Rie ^a   Fujishiro, Mitsuhiro ^a   Konno Shimizu, Maki ^a   Kato, Jun ^c   Kodashima, Shinya ^a   Ono, Satoshi ^a   Niimi, Keiko ^a   Mochizuki, Satoshi ^a   Tsuji, Yosuke ^a   Sakaguchi, Yoshiki ^a   Asada Hirayama, Itsuko ^a   Takeuchi, Chihiro ^a   Yakabi, Seiichi ^a   Kakimoto, Hikaru ^a   Wada, Ryoichi ^b   Mitsushima, Toru ^b   Ichinose, Masao ^c   Koike, Kazuhiko ^a   more..

^a UNIVERSITY OF TOKYO   (Japan)

^b KAMEDA MEDICAL CENTER   (Japan)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIUM ANTIBODY; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN G; PEPSINOGEN I; PEPSINOGEN II; PROTON PUMP INHIBITOR; BARIUM; CONTRAST MEDIUM;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; ATROPHIC GASTRITIS; BACTERIAL CLEARANCE; BARIUM MEAL; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOUBLE CONTRAST RADIOGRAPHY; DOUBLE CONTRAST UPPER GASTROINTESTINAL BARIUM X RAY RADIOGRAPHY; ENZYME BLOOD LEVEL; FEMALE; GASTROINTESTINAL RADIOGRAPHY; GASTROSCOPY; GENDER; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN G BLOOD LEVEL; JAPAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PEPSINOGEN I BLOOD LEVEL; PEPSINOGEN II BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SMOKING; STOMACH DISTENSION; UPPER GASTROINTESTINAL TRACT; YOUNG ADULT; CHRONIC DISEASE; COMPLICATION; ENDOSCOPY; GASTROINTESTINAL TRACT; MICROBIOLOGY; MULTIVARIATE ANALYSIS; NORMAL HUMAN; PHYSIOLOGY; RADIOGRAPHY; VERY ELDERLY; X RAY;

ADULT; AGED; AGED, 80 AND OVER; BARIUM; CHRONIC DISEASE; CONTRAST MEDIA; CROSS-SECTIONAL STUDIES; ENDOSCOPY; FEMALE; GASTRITIS, ATROPHIC; GASTROINTESTINAL TRACT; HEALTHY VOLUNTEERS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HISTAMINE H2 ANTAGONISTS; HUMANS; JAPAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROTON PUMP INHIBITORS; X-RAYS; YOUNG ADULT;

EID: 84908538417     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111359     Document Type: Article

References (43)

1. Crew KD, Neugut AI (2006) Epidemiology of gastric cancer. World J Gastroenterol 12: 354-362.
2. Yamamichi N, Inada K, Ichinose M, Yamamichi-Nishina M, Mizutani T, et al. (2007) Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state. Cancer Res 67: 10727-10735.
3. Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, et al. (2008) Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 9: 279-287.
4. Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, et al. (2006) Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan. Int J Cancer 118: 2315-2321.
5. Tsubono Y, Hisamichi S (2000) Screening for gastric cancer in Japan. Gastric Cancer 3: 9-18.
6. Oshima A, Hirata N, Ubukata T, Umeda K, Fujimoto I (1986) Evaluation of a mass screening program for stomach cancer with a case-control study design. Int J Cancer 38: 829-833.
7. Hisamichi S, Sugawara N (1984) Mass screening for gastric cancer by X-ray examination. Jpn J Clin Oncol 14: 211-223.
8. Mizoue T, Yoshimura T, Tokui N, Hoshiyama Y, Yatsuya H, et al. (2003) Prospective study of screening for stomach cancer in Japan. Int J Cancer 106: 103-107.
9. Hamashima C, Shibuya D, Yamazaki H, Inoue K, Fukao A, et al. (2008) The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol 38: 259-267.
10. Hosokawa O, Miyanaga T, Kaizaki Y, Hattori M, Dohden K, et al. (2008) Decreased death from gastric cancer by endoscopic screening: association with a population-based cancer registry. Scand J Gastroenterol 43: 1112-1115.
11. Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, et al. (2003) Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol 98: 735-739.
12. Nakajima S, Nishiyama Y, Yamaoka M, Yasuoka T, Cho E (2010) Changes in the prevalence of Helicobacter pylori infection and gastrointestinal diseases in the past 17 years. J Gastroenterol Hepatol 25 Suppl 1: S99-S110.
13. Lee SY, Park HS, Yu SK, Sung IK, Jin CJ, et al. (2007) Decreasing prevalence of Helicobacter pylori infection: a 9-year observational study. Hepatogastroenterology 54: 630-633.
14. Brown LM (2000) Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 22: 283-297.
15. Bures J, Kopacova M, Koupil I, Seifert B, Skodova Fendrichova M, et al. (2012) Significant decrease in prevalence of Helicobacter pylori in the Czech Republic. World J Gastroenterol 18: 4412-4418.
16. Dixon MF, Genta RM, Yardley JH, Correa P (1996) Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20: 1161-1181.
17. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, et al. (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345: 784-789.
18. Polk DB, Peek RM Jr (2010) Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 10: 403-414.
19. Satoh K, Kimura K, Taniguchi Y, Yoshida Y, Kihira K, et al. (1996) Distribution of inflammation and atrophy in the stomach of Helicobacter pyloripositive and -negative patients with chronic gastritis. Am J Gastroenterol 91: 963-969.
20. Ohkusa T, Fujiki K, Takashimizu I, Kumagai J, Tanizawa T, et al. (2001) Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. Ann Intern Med 134: 380-386.
21. Dheer S, Levine MS, Redfern RO, Metz DC, Rubesin SE, et al. (2002) Radiographically diagnosed antral gastritis: findings in patients with and without Helicobacter pylori infection. Br J Radiol 75: 805-811.
22. Rubesin SE, Levine MS, Laufer I (2008) Double-contrast upper gastrointestinal radiography: a pattern approach for diseases of the stomach. Radiology 246: 33-48.
23. Yamamichi N, Shimamoto T, Minatsuki C, Yoshida Y, Fujishiro M, et al. (2011) Postprandial fullness correlates with rapid inflow of gastric content into duodenum but not with chronic gastritis. BMC Gastroenterol 11: 140.
24. Kimura K (1972) Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 63: 584-592.
25. Kimura K, Takemoto T (1969) An Endoscopic Recognition of the Atrophic Border and its Significance in Chronic Gastritis. Endoscopy 3: 87-97.
26. Takahashi Y, Yamamichi N, Shimamoto T, Mochizuki S, Fujishiro M, et al. (2013) Helicobacter pylori infection is positively associated with gallstones: a large-scale cross-sectional study in Japan. J Gastroenterol.
27. Minatsuki C, Yamamichi N, Shimamoto T, Kakimoto H, Takahashi Y, et al. (2013) Background factors of reflux esophagitis and non-erosive reflux disease: a cross-sectional study of 10,837 subjects in Japan. PLoS One 8: e69891.
28. Shimamoto T, Yamamichi N, Kodashima S, Takahashi Y, Fujishiro M, et al. (2013) No association of coffee consumption with gastric ulcer, duodenal ulcer, reflux esophagitis, and non-erosive reflux disease: a cross-sectional study of 8,013 healthy subjects in Japan. PLoS One 8: e65996.
29. Tatemichi M, Sasazuki S, Inoue M, Tsugane S (2009) Clinical significance of IgG antibody titer against Helicobacter pylori. Helicobacter 14: 231-236.
30. Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, et al. (2004) Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 109: 138-143.
31. Oishi Y, Kiyohara Y, Kubo M, Tanaka K, Tanizaki Y, et al. (2006) The serum pepsinogen test as a predictor of gastric cancer: the Hisayama study. Am J Epidemiol 163: 629-637.
32. Watabe H, Mitsushima T, Yamaji Y, Okamoto M, Wada R, et al. (2005) Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 54: 764-768.
33. Shiota S, Murakami K, Fujioka T, Yamaoka Y (2010) Population-based strategies for Helicobacter pylori-associated disease management: a Japanese perspective. Expert Rev Gastroenterol Hepatol 4: 149-156.
34. Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, et al. (2001) Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects. Gut 49: 335-340.
35. Miki K (2006) Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer 9: 245-253.
36. Sung JJ, Lin SR, Ching JY, Zhou LY, To KF, et al. (2000) Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 119: 7-14.
37. Ito M, Haruma K, Kamada T, Mihara M, Kim S, et al. (2002) Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Aliment Pharmacol Ther 16: 1449-1456.
38. Kato M, Terao S, Adachi K, Nakajima S, Ando T, et al. (2013) Changes in endoscopic findings of gastritis after cure of H. pylori infection: multicenter prospective trial. Dig Endosc 25: 264-273.
39. Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, et al. (2000) Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst 92: 1881-1888.
40. Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V, et al. (2009) Metaanalysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med 151: 121-128.
41. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, et al. (2004) Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291: 187-194.
42. Leung WK, Lin SR, Ching JY, To KF, Ng EK, et al. (2004) Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut 53: 1244-1249.
43. Correa P, Houghton J (2007) Carcinogenesis of Helicobacter pylori. Gastroenterology 133: 659-672.